SCHEMBL4795441

SCHEMBL4795441

Fc1cccc(N2CC=CC2)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 3/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
HSD17B10 Q99714 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HCAR1 Q9BXC0 2/20 0.39
USP2 O75604 1/20 0.37
RXRA P19793 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4794953 0.82 PDE7A (0.38) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL4793090 0.81 SMN1; SMN2 (0.53) DRD3ALDH1A1KDM4ETSHRPOLB
SCHEMBL5716237 0.80 DRD2 (0.47) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL4793365 0.79 NOTUM (0.52) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL13382891 0.79 DRD2 (0.53) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL5716359 0.78 NPSR1 (0.49) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL5716477 0.77 ALDH1A1 (0.52) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL30839785 0.75 HTR1A (0.58) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL1441614 0.75 HTR1A (0.58) DRD2DRD3ALDH1A1KDM4ETSHR
SCHEMBL2317409 0.75 HSD17B10 (0.63) DRD2DRD3ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed